ALC vs RLAY
Alcon Inc vs Relay Therapeutics, Inc. — AI-powered side-by-side comparison
VS
RLAY
Relay Therapeutics, Inc.
65
Buy
| Metric | ALC | RLAY |
|---|
| AI Score |
68
|
65
|
| Price |
$75.39
|
$20.00
|
| P/E Ratio |
45.39×
|
-12.73×
|
| ROE |
4.4%
|
-48.8%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
54.9%
|
-566.6%
|
| Debt / Equity |
0.24×
|
0.03×
|
| Dividend Yield |
0.5%
|
0.0%
|
| RSI (14) |
73.4
|
66.0
|
| Beta |
0.703
|
1.704
|
| Expected Upside |
+11.3%
|
—
|
AI Committee View
Current Innellis committee reasoning for ALC versus RLAY.
ALC leads by 3 points.
ALC scores 68/100 (Buy) versus RLAY at 65/100 (Buy).
ALC Committee View
75% agreement
4 analysts
The primary driver is quarter-over-quarter growth rate is accelerating, not just positive. The main limiting factor is rsi at 73 is in overbought territory. The committee is constructive but not yet at full conviction.
Bull Case
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- MACD histogram positive -- bullish momentum — Technical
- VIX regime is low -- calm backdrop supports risk-taking — Macro
Bear Case
- RSI at 73 is in overbought territory — Technical
- Price trading above the upper Bollinger Band -- stretched — Technical
RLAY Committee View
67% agreement
6 analysts
The primary driver is low leverage (debt-to-equity 0.00) -- balance sheet can absorb a shock. The main limiting factor is roe of only -42.3% -- cheap may mean cheap for a reason. The committee is constructive but not yet at full conviction.
Bull Case
- Price structure making higher highs and higher lows — Technical
- Trend and market structure agree -- coherent bullish picture — Technical
- Weekly trend (uptrend) confirms the daily trend -- multi-timeframe agreement — Technical
Bear Case
- ROE of only -42.3% -- cheap may mean cheap for a reason — Value
- MACD histogram negative -- bearish momentum — Technical